US20451W1018
© BusinessWire
07.01.2026
CMPS
LISTED
NASDAQ
Compass Pathways Announces FDA Acceptance of IND Application for PTSD and Hosts Webinar on PTSD and TRD
News Preview
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, today announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for COMP360, enabling the initiation of a late-stage clinical trial in patients with PTSD. C...
Themefolio
Profiler
Peergroup
© BusinessWire
06.01.2026
CMPS
LISTED
NASDAQ
Compass Pathways Establishes Strategic Collaboration with Radial to Innovate Patient Experience and Inform Potential Delivery Model of COMP360
News Preview
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation announced today it is entering into its seventh strategic collaboration, with Radial Health, Inc., a growing national network of interventional psychiatry practices leveraging technology and operations expertise to opt...
Themefolio
Profiler
Peergroup
© BusinessWire
09.12.2025
CMPS
LISTED
NASDAQ
Compass Pathways to Host Webinar on Commercial Preparations for Treatment-Resistant Depression (TRD) and Clinical Trial Plans for Post-Traumatic Stress Disorder (PTSD) on January 7, 2026, 10:00am ET
News Preview
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will host a webinar to discuss the company’s commercial preparations for treatment-resistant depression (TRD) and clinical trial plans for post-traumatic stress disorde...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© BusinessWire
20.11.2025
CMPS
LISTED
NASDAQ
Compass Pathways to Participate in Two Investor Conferences in December
News Preview
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in the following December investor conferences:
8th Annual Evercore Healthcare Conference – Coral Gables, FL: Fireside chat at 10:00am ET on Decembe...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
05.11.2025
CMPS
LISTED
NASDAQ
Compass Pathways to Participate in Stifel 2025 Healthcare Conference
News Preview
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in the Stifel 2025 Healthcare Conference in New York, NY at 10:40 am ET on Tuesday, November 11, 2025.
A live audio webcast of these events will be a...
Themefolio
Profiler
Peergroup
© BusinessWire
04.11.2025
CMPS
LISTED
NASDAQ
Compass Pathways Announces Third Quarter 2025 Financial Results and Business Highlights Including Acceleration of Commercial Launch Plans by 9-12 Months
News Preview
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported its financial results for the third quarter 2025 and provided an update on recent progress across its business.
“With the completion of COMP006 enrollment and our recent positive disc...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
CMPS
LISTED
NASDAQ
NeuroKaire Enters into R&D Collaboration with Compass Pathways to Pioneer Precision Treatments for Depression
News Preview
Collaboration will leverage AI-powered neural analysis and Compass' expertise in psychedelic drug development to advance new therapies for mental health
KEARNY, N.J., Oct. 30, 2025 /PRNewswire/ -- NeuroKaire, a pioneer in precision psychiatry and neurology, has...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
CMPS
LISTED
NASDAQ
Compass Pathways Appoints Dr. Jeffrey Jonas to Board of Directors
News Preview
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the appointment of Dr. Jeffrey Jonas to its Board of Directors, effective immediately. Dr. Jonas brings more than three decades of leadership in pharmaceutical research and development...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
CMPS
LISTED
NASDAQ
Compass Pathways to Announce Third Quarter Financial Results on November 4, 2025
News Preview
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the third quarter ended September 30, 2025, and provide an update on recent developments, on November 4, 2025.
Compass management will host...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
CMPS
LISTED
NASDAQ
Compass Pathways Announces Publication of Results from Phase 2 Study of COMP360 Psilocybin for Post-Traumatic Stress Disorder
News Preview
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the publication of results from an open-label Phase 2 study evaluating the safety and tolerability of a single-dose of 25 mg of investigational COMP360 synthetic psilocybin treatment i...
Themefolio
Profiler
Peergroup
© BusinessWire
27.08.2025
CMPS
LISTED
NASDAQ
Compass Pathways to Participate in Four Investor Conferences in September
News Preview
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in the following September investor conferences:
Cantor Global Healthcare Conference – New York, NY: Fireside chat at 1:35 PM EST on September 3, 20...
Themefolio
Profiler
Peergroup
© BusinessWire
31.07.2025
CMPS
LISTED
NASDAQ
Compass Pathways Announces Second Quarter 2025 Financial Results and Business Highlights
News Preview
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported its financial results for the second quarter 2025 and provided an update on recent progress across its business.
“With the recent positive 6-week primary endpoint from our first COMP3...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
29.07.2025
CMPS
LISTED
NASDAQ
Compass Pathways Appoints Justin Gover to Board of Directors
News Preview
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the appointment of Justin Gover to its Board of Directors, effective immediately. Mr. Gover brings more than 25 years of leadership in the biopharmaceutical industry to this role.
As...
Themefolio
Profiler
Peergroup
© BusinessWire
22.07.2025
CMPS
LISTED
NASDAQ
Compass Pathways to Announce Second Quarter Financial Results on July 31, 2025
News Preview
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the second quarter ended June 30, 2025, and provide an update on recent developments, on July 31, 2025.
Compass management will host a conf...
Themefolio
Profiler
Peergroup
© BusinessWire
10.07.2025
CMPS
LISTED
NASDAQ
Compass Pathways to Participate in HC Wainwright @Home Series Interview on July 14th, 8:00am ET
News Preview
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in a fireside chat with Patrick Trucchio, Managing Director Equity Research at HC Wainwright at 8:00 am ET on July 14th, 2025.
A live audio webcast o...
Themefolio
Profiler
Peergroup
© BusinessWire
23.06.2025
CMPS
LISTED
NASDAQ
Compass Pathways Successfully Achieves Primary Endpoint in First Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression
News Preview
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the successful achievement of the primary endpoint in the ongoing Phase 3 COMP005 trial, the first of two Phase 3 trials evaluating COMP360, a synthetic, proprietary formulation of psilocybin, for trea...
Themefolio
Profiler
Peergroup
© BusinessWire
14.05.2025
CMPS
LISTED
NASDAQ
Compass Pathways to Participate in 2025 RBC Capital Markets Global Healthcare Conference
News Preview
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in a fireside chat at the 2025 RBC Capital Markets Global Healthcare Conference at 10:30 am ET on May 20th, 2025.
A live audio webcast of the presenta...
Themefolio
Profiler
Peergroup
© BusinessWire
08.05.2025
CMPS
LISTED
NASDAQ
Compass Pathways Announces First Quarter 2025 Financial Results and Business Highlights
News Preview
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported its financial results for the first quarter 2025 and provided an update on recent progress across its business.
“We eagerly await the upcoming topline 6-week data readout, on track for...
Themefolio
Profiler
Peergroup
© BusinessWire
29.04.2025
CMPS
LISTED
NASDAQ
Compass Pathways Establishes Strategic Collaboration with HealthPort to Inform the Potential Delivery of COMP360 Synthesized Psilocybin Treatment in Underserved Communities
News Preview
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation announced today it is entering into a strategic collaboration with HealthPort, a multi-site comprehensive community health organization. HealthPort employs an integrated model centered around social determinants of hea...
Themefolio
Profiler
Peergroup
© BusinessWire
28.04.2025
CMPS
LISTED
NASDAQ
Compass Pathways to Announce First Quarter Financial Results on May 8, 2025
News Preview
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the first quarter ended March 31, 2025, and provide an update on recent developments, on May 8, 2025.
Compass management will host a confere...
Themefolio
Profiler
Peergroup
© BusinessWire
22.04.2025
CMPS
LISTED
NASDAQ
Compass Pathways Announces Dosing Complete for All Participants in Part A of Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression
News Preview
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, today announced that all participants have completed dosing in Part A of the COMP005 phase 3 trial for treatment resistant depression (TRD). Following pre-dosing activities, including washout from anti-depressant medi...
Themefolio
Profiler
Peergroup
© BusinessWire
26.03.2025
CMPS
LISTED
NASDAQ
Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression
News Preview
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, today announced the completion of recruitment in the COMP005 phase 3 trial for treatment resistant depression (TRD). The final participants are completing pre-dosing activities, including washout from anti-depressant...
Themefolio
Profiler
Peergroup
© BusinessWire
18.03.2025
CMPS
LISTED
NASDAQ
Compass Pathways Announces Publication of Results from COMP004 Study on COMP360 Psilocybin for Treatment-Resistant Depression
News Preview
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, today announced the publication of results from the COMP004 study, an observational 52-week follow-up from the Phase 2 COMP001 and COMP003 trials of COMP360 psilocybin treatment in patients with treatment-resistant de...
Themefolio
Profiler
Peergroup
© BusinessWire
11.03.2025
CMPS
LISTED
NASDAQ
Compass Pathways to Participate in Stifel Virtual CNS Forum
News Preview
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will present at the Stifel Virtual CNS Forum at 11:30 am ET on March 18th, 2025.
A live audio webcast of the presentation will be accessible from the “Events” page of...
Themefolio
Profiler
Peergroup
© BusinessWire
27.02.2025
CMPS
LISTED
NASDAQ
Compass Pathways Announces Fourth Quarter and Full-Year 2024 Financial Results and Business Highlights
News Preview
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported its financial results for the fourth quarter and full year 2024 and provided an update on recent progress across its business.
“We are excited that the first data readout from our piv...
Themefolio
Profiler
Peergroup
© BusinessWire
25.02.2025
CMPS
LISTED
NASDAQ
Compass Pathways to Participate in TD Cowen 45th Annual Health Care Conference
News Preview
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will present at the TD Cowen 45th Annual Health Care Conference at 1:10 pm ET on March 3rd, 2025.
A live audio webcast of the presentation will be accessible from the...
Themefolio
Profiler
Peergroup
© BusinessWire
18.02.2025
CMPS
LISTED
NASDAQ
Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025
News Preview
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the fourth quarter 2024 ending December 31, 2024, and provide an update on recent developments, on February 27th, 2025.
Compass management w...
Themefolio
Profiler
Peergroup
© BusinessWire
05.02.2025
CMPS
LISTED
NASDAQ
Compass Pathways to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference
News Preview
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference at 8:40 am ET on February 12th, 2025.
A live audio webcast of the presentation will be...
Themefolio
Profiler
Peergroup
© BusinessWire
21.01.2025
CMPS
LISTED
NASDAQ
Compass Pathways Appoints Steve Levine, M.D., as Chief Patient Officer
News Preview
Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating access to evidence-based innovation in mental health, today announced the appointment of Steve Levine, M.D., as Chief Patient Officer, effective immediately. In this newly developed executive team role, Dr. Levine will be responsible for ensuring tha...
Themefolio
Profiler
Peergroup
© BusinessWire
10.01.2025
CMPS
LISTED
NASDAQ
Compass Pathways Announces Pricing of Underwritten Offering
News Preview
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the pricing of an underwritten offering of 24,014,728 American Depositary Shares (“ADSs”) and in lieu of ADS, to certain institutional investors, pre-funded warrants to purchase up to...
Themefolio
Profiler
Peergroup
© BusinessWire
18.12.2024
CMPS
LISTED
NASDAQ
Compass Pathways to Be Added to the NASDAQ Biotechnology Index (NBI)
News Preview
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today its common stock will be added to the NASDAQ Biotechnology Index (Nasdaq: NBI), effective prior to market open on Monday, December 23, 2024.
The NASDAQ Biotechnology Index is designe...
Themefolio
Profiler
Peergroup
© BusinessWire
25.11.2024
CMPS
LISTED
NASDAQ
Compass Pathways to Participate in December Investor Conferences
News Preview
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that members of the executive management team will participate in the following investor conferences in addition to hosting investor meetings:
7th Annual Evercore ISI HealthCONx Con...
Themefolio
Profiler
Peergroup
© BusinessWire
31.10.2024
CMPS
LISTED
NASDAQ
Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates
News Preview
Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating access to evidence-based innovation in mental health, today reported its financial results for the third quarter 2024 and an update on recent business progress.
“Ensuring the success of our lead COMP360 program is our absolute priority. We remain co...
Themefolio
Profiler
Peergroup
© BusinessWire
24.10.2024
CMPS
LISTED
NASDAQ
Compass Pathways to Announce Third Quarter Financial Results on October 31, 2024
News Preview
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the third quarter 2024 ending September 30, 2024, and provide an update on recent business developments, on October 31, 2024.
The management...
Themefolio
Profiler
Peergroup
© BusinessWire
23.09.2024
CMPS
LISTED
NASDAQ
Compass Pathways to Participate in Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit
News Preview
Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating access to evidence-based innovation in mental health, announced today that executives from the management team will be participating in a fireside chat at the Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit on September 26, 2024 at...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.08.2024
CMPS
LISTED
NASDAQ
Compass Pathways to participate in three investor conferences in September
News Preview
LONDON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in the following September investor conferences:...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.07.2024
CMPS
LISTED
NASDAQ
Compass Pathways to announce second quarter financial results on August 1, 2024
News Preview
LONDON, July 24, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the second quarter 2024 ending June 30, 2024, and provide an update on recent business development...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.06.2024
CMPS
LISTED
NASDAQ
Compass Pathways to participate in upcoming H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
News Preview
LONDON, June 24, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will hold a fireside chat at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference at 7:00 am ET on June 27, 2...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.05.2024
CMPS
LISTED
NASDAQ
Compass Pathways to announce first quarter financial results on May 8, 2024
News Preview
LONDON, May 03, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the first quarter 2024 ending March 31, 2024, and provide an update on recent business developments...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
